soluble human insulin

DRUG6 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Phase 4

Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

CompletedNCT00571935

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2003-08-31End: 2004-10-31Updated: 2016-12-21

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

CompletedNCT00593255

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2004-07-31End: 2005-04-30Updated: 2016-12-22

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

CompletedNCT00597233

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2002-10-31End: 2002-12-31Updated: 2016-12-22

Unknown Phase

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

CompletedNCT00410033

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 1989-12-31End: 2006-05-31Updated: 2016-12-22

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

CompletedNCT00698126

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2007-10-31End: 2009-05-31Updated: 2016-10-28

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

CompletedNCT00715780

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2008-06-30End: 2009-07-31Updated: 2016-11-07

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01